+1 (314) 370-6046 oderKontakt

Anti-FCER1A Antikörper [CRA2] (A420)

$535

Monoklonal [CRA2] Maus Antikörper gegen FCER1A für WB, IHC-Fr, IHC-P, ICC und FC.

Versandkosten
Vorlaufzeit
Lieferung in 4-6 Werktagen
Telefon
+1 (314) 370-6046
Mo bis Frei, 8am - 4pm AST
Email
orders@antibodies.com
Produktname
Anti-FCER1A Antibody [CRA2]
Beschreibung
Mouse monoclonal (CRA2) antibody to FCER1A.
Anwendungen
WB, IHC-Fr, IHC-P, ICC, FC
Verdünnungen
WB: 1 µg/ml
Reaktivität
Human
Immunogen
Recombinant extracellular portion of human FCER1A protein (corresponding to a.a. Met-26-197, where signal peptide is 1-25).
Wirt
Mouse
Klonalität
Monoclonal
Klon
CRA2
Isotyp
IgG1
Konjugat

Unconjugated

Reinigung
Affinity purification.
Konzentration
1 mg/ml
Produktform
Liquid
Formulierung
Supplied in Phosphate Buffered Saline, pH 7.4, with 50% Glycerol (filter sterilised, without Sodium Azide, and carrier free).
Lagerung
Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.
Synonyme
Fc epsilon RI, Fc epsilon RI alpha, Fc epsilon RI alpha chain, Fc epsilon RI alpha-chain, Fc fragment of IgE high affinity I receptor for alpha polypeptide, Fc fragment of IgE, high affinity I, receptor for, alpha subunit, Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide, Fc IgE receptor alpha polypeptide, Fc IgE receptor, alpha chain, Fc IgE receptor, alpha polypeptide, Fc of IgE high affinity I receptor for alpha polypeptide, Fc-epsilon RI-alpha, FCE 1A, FCE1A, FCER 1A, FCERA_HUMAN, FcERI, FceRI alpha, high affinity IgE receptor, High affinity immunoglobulin epsilon receptor alpha subunit, high affinity immunoglobulin epsilon receptor alpha-subunit, High affinity immunoglobulin epsilon receptor subunit alpha, IgE Fc receptor alpha subunit, IgE Fc receptor subunit alpha, Immunoglobulin E receptor high affinity of mast cells alpha polypeptide, immunoglobulin E receptor, high-affinity, of mast cells, alpha polypeptide
Haftungsausschluss
Dieses Produkt ist nur für Forschungszwecke bestimmt. Es ist nicht für diagnostische oder therapeutische Zwecke bestimmt.

Alternative Produkte zum Anti-FCER1A Antikörper [CRA2] (A420)

Oben